索引超出了数组界限。 文章摘要
|本期目录/Table of Contents|

[1]张航,石凤梧.功能性三尖瓣反流的治疗进展[J].国际心血管病杂志,2023,03:129-133.
点击复制

功能性三尖瓣反流的治疗进展(PDF)

《国际心血管病杂志》[ISSN:1006-6977/CN:61-1281/TN]

期数:
2023年03期
页码:
129-133
栏目:
综述
出版日期:
2023-05-30

文章信息/Info

Title:
-
作者:
张航; 石凤梧
050004 石家庄，河北医科大学第二医院心脏外科
Author(s):
-
关键词:
功能性三尖瓣反流; 外科治疗; 介入治疗; 瓣膜病
Keywords:
-
分类号:
-
DOI:
10.3969/j.issn.1673-6583.2023.03.001
文献标识码:
-
摘要:
功能性三尖瓣反流（FTR）是最常见的三尖瓣反流。既往观点认为，在左心瓣膜病变或左向右分流先天性心脏病矫治后，不需特殊处理三尖瓣，FTR会逐步减轻甚至消失。然而，研究发现大部分患者的左心系统瓣膜问题矫正后，依然存在三尖瓣反流，甚至反流程度会更加严重，FTR成为心血管领域所需探讨的重要内容。该文介绍近年来FTR的外科治疗和介入治疗进展，旨在提升对FTR的认知，提高FTR的整体诊治效率。
Abstract:
-

参考文献/References

[1]Itagaki S, Hosseinian L, Varghese R. Right ventricular failure after cardiac surgery: management strategies[J]. Semin Thorac Cardiovasc Surg, 2012, 24(3):188-194.
[2]Buckberg G, Hoffman JIE. Right ventricular architecture responsible for mechanical performance: unifying role of ventricular septum[J]. J Thorac Cardiovasc Surg, 2014, 148(6):3166-3171.
[3]Rudski LG, Lai WW, Afilalo J, et al. Guidelines for the echocardiographic assessment of the right heart in adults:a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography[J]. J Am Soc Echocardiogr, 2010, 23(7):685-713.
[4] 王媛, 孟真, 吴永健. 经导管介入治疗三尖瓣关闭不全的研究进展[J]. 中国循环杂志, 2019, 34(2):205-208.
[5]Onorati F, Santarpino G, Marturano D, et al. Successful surgical treatment of chronic ischemic mitral regurgitation achieves left ventricular reverse remodeling but does not affect right ventricular function[J]. J Thorac Cardiovasc Surg, 2009, 138(2):341-351.
[6]Desai RR, Vargas Abello LM, Klein AL, et al. Tricuspid regurgitation and right ventricular function after mitral valve surgery with or without concomitant tricuspid valve procedure[J]. J Thorac Cardiovasc Surg, 2013, 146(5):1126-1132.
[7]Kay JH, Mendez AM, Zubiate P. A further look at tricuspid annuloplasty[J]. Ann Thorac Surg, 1976, 22(5):498-500.
[8]Katircioglu SF, Yamak B, Ulus AT, et al. Treatment of functional tricuspid regurgitation by bicuspidalization annuloplasty during mitral valve surgery[J]. J Heart Valve Dis, 1997, 6(6):631-635.
[9]Ko?mider A, Zas?onka J, Jaszewski R, et al. Tricuspid valve annuloplasty: early and long-term results (13 years follow-up:1988-2001)[J]. Acta Cardiol, 2004, 59(2):205-206.
[10] Minale C, Lambertz H, Nikol S, et al. Selective annuloplasty of the tricuspid valve. Two-year experience[J]. J Thorac Cardiovasc Surg, 1990, 99(5):846-851.
[11] Gatti G, Pacilli P, Pugliese P. Tricuspid valve annuloplasty using a partial flexible ring: mid-term follow-up[J]. Ital Heart J, 2003, 4(2):121-124.
[12] Filsoufi F, Salzberg SP, Abascal V, et al. Surgical management of functional tricuspid regurgitation with a new remodeling annuloplasty ring[J]. Mt Sinai J Med, 2006, 73(6):874-879.
[13] 吴清玉, 张怀军, 许建屏. 三尖瓣置换术55例临床分析[J]. 中华心血管病杂志, 2000, 28(3):210.
[14] 刘晓芹, 王伟, 仲秀玲, 等. 我国心脏康复研究现状及问题的文献计量学评价[J]. 实用心脑肺血管病杂志, 2019, 27(1):5-8.
[15] Latib A, Colombo A, Regazzoli D. Tricuspid regurgitation:from physiopathology to transcatheter interventions[J]. Minerva Cardioangiol, 2018, 66(6):671-672.
[16] Lauten A, Dreger H, Schofer J, et al. Caval valve implantation for treatment of severe tricuspid regurgitation[J]. J Am Coll Cardiol, 2018, 71(10):1183-1184.
[17] 吕彦萌, 陆方林. 经导管介入治疗三尖瓣病变装置的研究进展[J]. 中国胸心血管外科临床杂志, 2018, 25(4):345-349.
[18] Besler C, Blazek S, Rommel KP, et al. Combined mitral and tricuspid versus isolated mitral valve transcatheter edge-to-edge repair in patients with symptomatic valve regurgitation at high surgical risk[J]. JACC Cardiovasc Interv, 2018,11(12):1142-1151.
[19] Besler C, Orban M, Rommel KP, et al. Predictors of procedural and clinical outcomes in patients with symptomatic tricuspid regurgitation undergoing transcatheter edge-to-edge repair[J]. JACC Cardiovasc Interv, 2018, 11(12):1119-1128.
[20] Lauten A, Ferrari M, Hekmat K, et al. Heterotopic transcatheter tricuspid valve implantation: first-in-man application of a novel approach to tricuspid regurgitation[J]. Eur Heart J, 2011, 32(10):1207-1213.
[21] Rodés-Cabau J, Hahn RT, Latib A, et al. Transcatheter therapies for treating tricuspid regurgitation[J]. J Am Coll Cardiol, 2016, 67(15):1829-1845.
[22] Lauten A, Doenst T, Hamadanchi A, et al. Percutaneous bicaval valve implantation for transcatheter treatment of tricuspid regurgitation: clinical observations and 12-month follow-up[J]. Circ Cardiovasc Interv, 2014, 7(2):268-272.
[23] Laule M, Stangl V, Sanad W, et al. Percutaneous transfemoral management of severe secondary tricuspid regurgitation with Edwards Sapien XT bioprosthesis: first-in-man experience[J]. J Am Coll Cardiol, 2013, 61(18):1929-1931.
[24] Rahhab Z, Kortlandt FA, Velu JF, et al. Current MitraClip experience, safety and feasibility in the Netherlands[J]. Neth Heart J, 2017, 25(6):394-400.
[25] Hammerstingl C, Schueler R, Malasa M, et al. Transcatheter treatment of severe tricuspid regurgitation with the MitraClip system[J]. Eur Heart J, 2016, 37(10):849-853.
[26] Braun D, Nabauer M, Massberg S, et al. Transcatheter repair of primary tricuspid valve regurgitation using the MitraClip system[J]. JACC Cardiovasc Interv, 2016, 9(15):e153-e154.
[27] Campelo-Parada F, Perlman G, Philippon F, et al. First-in-man experience of a novel transcatheter repair system for treating severe tricuspid regurgitation[J]. J Am Coll Cardiol, 2015, 66(22):2475-2483.
[28] Schofer J, Bijuklic K, Tiburtius C, et al. First-in-human transcatheter tricuspid valve repair in a patient with severely regurgitant tricuspid valve[J]. J Am Coll Cardiol, 2015, 65(12):1190-1195.
[29] Ristalli F, Meucci F, Stolcova M, et al. MitraClip implantation to treat early recurrence of mitral regurgitation after percutaneous direct annuloplasty with cardioband[J]. JACC Cardiovasc Interv, 2018, 11(14):1416-1417.
[30] Rogers JH. Functional tricuspid regurgitation: percutaneous therapies needed[J]. JACC Cardiovasc Interv, 2015, 8(3):492-494.
[31] 陈茂, 荆志成, 张浩, 等. 经导管三尖瓣置换治疗的现状与挑战[J]. 中华心血管病杂志, 2021, 49(5):420-424.
[32] Hahn RT, Kodali S, Fam N, et al. Early multinational experience of transcatheter tricuspid valve replacement for treating severe tricuspid regurgitation[J]. JACC Cardiovasc Interv, 2020, 13(21):2482-2493.
[33] Lu F, Qiao F, Lv Y, et al. A radial force-independent bioprosthesis for transcatheter tricuspid valve implantation in a preclinical model[J]. Int J Cardiol, 2020, 319:120-126.
[34] Lu FL, Ma Y, An Z, et al. First-in-man experience of transcatheter tricuspid valve replacement with LuX-Valve in high-risk tricuspid regurgitation patients[J]. JACC Cardiovasc Interv, 2020, 13(13):1614-1616.
[35] 陈思, 顾君君, 杨帆, 等. LuX-Valve系统经导管三尖瓣置换26例近期疗效分析[J]. 中国心血管病研究, 2022, 20(2):104-107.

备注/Memo

备注/Memo:
通信作者：石凤梧， E-mail：shifengwu65@163.com
更新日期/Last Update: 2023-05-30